Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
- 1 November 2008
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 249 (2) , 601-613
Abstract
Purpose: To investigate whether estimates of relative cerebral blood volume (rCBV) in brain tumors, obtained by using dynamic susceptibility-weighted contrast material–enhanced magnetic resonance (...Keywords
This publication has 48 references indexed in Scilit:
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasationMagnetic Resonance in Medicine, 2005
- Analysis of dynamic contrast enhanced MRIBritish Journal of Radiology, 2004
- Measuring blood volume and vascular transfer constant from dynamic, T‐weighted contrast‐enhanced MRIMagnetic Resonance in Medicine, 2004
- Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imagingMagnetic Resonance in Medicine, 2002
- Perfusion MR Imaging: Clinical Utility for the Differential Diagnosis of Various Brain TumorsKorean Journal of Radiology, 2002
- Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumorsJournal of Neurosurgery, 1997
- AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance NeuroimagesComputers and Biomedical Research, 1996
- Ultrafast imaging of brain tumorsTopics in Magnetic Resonance Imaging, 1993